PDF-Guidance on Electioneering Activities PDF document

This guidance note serves as a general under the Personal Data Privacy Ordinance the 147148 in relation to electioneering candidates andor their election agents

Upload by giovanna-bartolotta
Published on 2016-03-19

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/262423" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Guidance on Electioneering Activities" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Guidance on Electioneering Activities: Transcript

PDF-Guidance on Electioneering Activities PDF document

Presentation Embed Code

Download Presentation

Guidance on Electioneering Activities: Transcript

Related Contents

Electioneering Communications Brochure Electioneering

Electioneering Communications Brochure Electioneering

Education , Advocacy, Lobbying & Electioneering

Electioneering

Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A

Tutor guidance notes

Keep It FairPolling Place Rules for Election Day and Early VotingThis

Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE

Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance

Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish

Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination

Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment

Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT

Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs